Cyriac Roeding

Headshot portrait of Earli CEO Cyriac Roeding, wearing black-rimmed glasses, smiling at the camera.

Earli

Cyriac Roeding is a Silicon Valley-based German-American entrepreneur and angel investor. He serves as the Co-founder and CEO of Earli, an early cancer detection and treatment firm headquartered in South San Francisco. Earli is based on Synthetic Biopsy technology from Stanford University and is funded by leading venture captial firms including Andreessen Horowitz and Khosla Ventures.

Videos

Left to right: Cyriac Roeding (Earli), Fabian Theis (Helmholtz Munich) and Eva Maydell, (Member of the European Parliament) in conversation with Stefan Druessler (UnternehmerTUM/Rise Europe) on stage at the DLD Munich Conference 2025.

A Push for Europe

How can Europe leverage its strength in science and research to become a global innovation leader? This DLD25 panel discussion, moderated by Stefan Drüssler (UnternehmerTUM), offers a range of different perspectives from EU…
Video details

Articles

Computer illustration of a cancer cell

Turning Cancer Against Itself

Californian startup Earli aims to outsmart one of the world’s deadliest diseases by combining biology, engineering and software. CEO Cyriac Roeding shares details with DLD.
Article details

Events

DLD25 graphic design

DLD Munich 2025

Europe’s leading innovation conference celebrates its 20th anniversary from January 16-18, 2025, in Munich. Find out about speakers, location details and how to attend…
Event details
magnifiercrosschevron-downmenu-circle
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram